Expression of engrailed homeobox 2 regulates the proliferation, migration and invasion of non‑small cell lung cancer cells

Lin,Xiangxiao; Liu,Xincun; Gong,Cunqi

doi:10.3892/ol.2018.8693

Expression of engrailed homeobox 2 regulates the proliferation, migration and invasion of non‑small cell lung cancer cells

Authors:
- Xiangxiao Lin
- Xincun Liu
- Cunqi Gong
View Affiliations

Affiliations: Respiratory Department, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China, Department of Clinical Laboratory, Jining No. 1 People's Hospital, Jining, Shandong 272000, P.R. China
Published online on: May 10, 2018 https://doi.org/10.3892/ol.2018.8693
Pages: 536-542

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the expression, biological function and mechanism of action of engrailed homeobox 2 (EN2) in non‑small cell lung cancer (NSCLC) at the tissue and cellular level. A total of 42 patients who underwent surgical resection of NSCLC tissues between January 2014 and January 2015 were included in the present study. EN2 mRNA expression levels in explanted NSCLC tissues were determined using reverse‑transcription quantitative polymerase chain reaction analysis. Adenocarcinoma human alveolar basal epithelial A549 cells were transfected with negative control plasmids or those containing EN2, enabling its overexpression. To assess the effect of EN2 overexpression in A549 cells, a Cell Counting kit‑8 assay was used to analyze cellular proliferation, a Transwell assay was used to evaluate cellular migration and invasion and flow cytometry was used to detect the cell cycle distribution. To measure protein expression of EN2 and β‑catenin in A549 cells, western blotting was also conducted. EN2 mRNA expression levels in NSCLC tissues were lower than those in normal tissues, and were associated with metastasis, clinical staging and differentiation degrees of NSCLC. Increased expression of EN2 inhibited the proliferation of A549 cells in vitro, and suppressed their migration and invasion. Elevated EN2 expression inhibited the proliferation of A549 cells by regulating the G1/S phase transition. β‑catenin protein expression levels and nuclear translocation in A549 cells were inhibited by EN2 overexpression. The present study demonstrated that expression of EN2 in NSCLC tissues was downregulated and negatively associated with the degree of disease differentiation, lymphatic metastasis and clinical staging. Overexpression of EN2 inhibits the proliferation, migration and invasion of A549 cells, as well as the expression of β‑Catenin and nuclear translocation.

View Figures

View References

1	Zhang YZ, Chen X, Fan XX, He JX, Huang J, Xiao DK, Zhou YL, Zheng SY, Xu JH, Yao XJ, et al: Compound library screening identified cardiac glycoside digitoxin as an effective growth inhibitor of gefitinib-resistant non-small cell lung cancer via downregulation of α-tubulin and inhibition of microtubule formation. Molecules. 21:3742016. View Article : Google Scholar : PubMed/NCBI
2	Zheng H, Wang M, Wu J, Wang ZM, Nan HJ and Sun H: Inhibition of mTOR enhances radiosensitivity of lung cancer cells and protects normal lung cells against radiation. Biochem Cell Biol. 94:213–220. 2016. View Article : Google Scholar : PubMed/NCBI
3	Trinidad López C, Bayarri Souto M, Pernas Oca R, Sánchez-Gracián Delgado C, Vázquez González M, Liste Vaamonde A, De La Fuente Tardáguila G and De La Fuente Aguado J: Characteristics of computed tomography perfusion parameters in non-small-cell-lung-cancer and its relationship to histology, size, stage an treatment response. Clin Imaging. 50:5–12. 2017. View Article : Google Scholar : PubMed/NCBI
4	Wei H, Su M, Lin R, Li H and Zou C: Prognostic factors analysis in EGFR mutation-positive non-small cell lung cancer with brain metastases treated with whole brain-radiotherapy and EGFR-tyrosine kinase inhibitors. Oncol Lett. 11:2249–2254. 2016. View Article : Google Scholar : PubMed/NCBI
5	Zhao T, Gao Z, Wu W, He W and Yang YI: Effect of synchronous solitary bone metastasectomy and lung cancer resection on non-small cell lung cancer patients. Oncol Lett. 11:2266–2270. 2016. View Article : Google Scholar : PubMed/NCBI
6	Lee P, Leung CC, Restrepo MI, Takahashi K, Song Y and Porcel JM: Year in review 2015: Lung cancer, pleural diseases, respiratory infections, bronchiectasis and tuberculosis, bronchoscopic intervention and imaging. Respirology. 21:961–967. 2016. View Article : Google Scholar : PubMed/NCBI
7	Matsumoto M, Nakajima W, Seike M, Gemma A and Tanaka N: Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells. Biochem Biophys Res Commun. 473:490–496. 2016. View Article : Google Scholar : PubMed/NCBI
8	Rocco G, Nason K, Brunelli A, Varela G, Waddell T and Jones DR: Management of stage IIIA (N2) non-small cell lung cancer: A transatlantic perspective. J Thorac Cardiovasc Surg. 151:1235–1238. 2016. View Article : Google Scholar : PubMed/NCBI
9	Parrillo L, Costa V, Raciti GA, Longo M, Spinelli R, Esposito R, Nigro C, Vastolo V, Desiderio A, Zatterale F, et al: Hoxa5 undergoes dynamic DNA methylation and transcriptional repression in the adipose tissue of mice exposed to high-fat diet. Int J Obes (Lond). 40:929–937. 2016. View Article : Google Scholar : PubMed/NCBI
10	Morgan R and El-Tanani M: Hox genes as potential markers of circulating tumour cells. Curr Mol Med. 16:322–327. 2016. View Article : Google Scholar : PubMed/NCBI
11	Sandberg ES, Calikoglu AS, Loechner KJ and Snyder LL: Short stature homeobox-containing haploinsufficiency in seven siblings with short stature. Case Rep Endocrinol. 2017:72873512017.PubMed/NCBI
12	Catela C, Shin MM, Lee DH, Liu JP and Dasen JS: Hox proteins coordinate motor neuron differentiation and connectivity programs through ret/gfralpha genes. Cell Rep. 14:1901–1915. 2016. View Article : Google Scholar : PubMed/NCBI
13	Krumlauf R: Hox genes and the hindbrain: A study in segments. Curr Top Dev Biol. 116:581–596. 2016. View Article : Google Scholar : PubMed/NCBI
14	Zhong Z, Shan M, Wang J, Liu T, Xia B, Niu M, Ren Y and Pang D: HOXD13 methylation status is a prognostic indicator in breast cancer. Int J Clin Exp Pathol. 8:10716–10724. 2015.PubMed/NCBI
15	Aquino G, Franco R, Sabatino R, Mantia EL, Scognamiglio G, Collina F, Longo F, Ionna F, Losito NS, Liguori G, et al: Deregulation of paralogous 13 HOX genes in oral squamous cell carcinoma. Am J Cancer Res. 5:3042–3055. 2015.PubMed/NCBI
16	DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, Schultz RT, Crawley J and Young LJ: The developmental neurobiology of aut-ism spectrum disorder. J Neurosci. 26:6897–6906. 2006. View Article : Google Scholar : PubMed/NCBI
17	Ranzi AD, da Silva JN, Graziottin TM, Annels N and Bica CG: Immunohistochemistry biomarkers in nonmuscle invasive bladder cancer. Appl Immunohistochem Mol Morphol. 25:178–183. 2017. View Article : Google Scholar : PubMed/NCBI
18	McGrath SE, Michael A, Morgan R and Pandha H: EN2 in prostate cancer. Adv Clin Chem. 71:47–76. 2015. View Article : Google Scholar : PubMed/NCBI
19	Kaur H, Sehgal IS, Bal A, Gupta N, Behera D, Das A and Singh N: Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key. Indian J Cancer. 54:285–290. 2017. View Article : Google Scholar : PubMed/NCBI
20	Cepollaro S, Della Bella E, de Biase D, Visani M and Fini M: Evaluation of RNA from human trabecular bone and identification of stable reference genes. J Cell Physiol. 233:4401–4407. 2018. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Omi M, Harada H, Watanabe Y, Funahashi J and Nakamura H: Role of En2 in the tectal laminar formation of chick embryos. Development. 141:2131–2138. 2014. View Article : Google Scholar : PubMed/NCBI
23	Martin NL, Saba-El-Leil MK, Sadekova S, Meloche S and Sauvageau G: EN2 is a candidate oncogene in human breast cancer. Oncogene. 24:6890–6901. 2005. View Article : Google Scholar : PubMed/NCBI
24	Bose SK, Bullard RS and Donald CD: Oncogenic role of engrailed-2 (en-2) in prostate cancer cell growth and survival. Transl Oncogenomics. 3:37–43. 2008.PubMed/NCBI
25	Morgan R, Bryan RT, Javed S, Launchbury F, Zeegers MP, Cheng KK, James ND, Wallace DM, Hurst CD, Ward DG, et al: Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. Eur J Cancer. 49:2214–2222. 2013. View Article : Google Scholar : PubMed/NCBI
26	Lai CY, Pan B, Luo Y, Liang WB, Chen J, Ye DM, Guo JN, Li L and Su ZX: Engrailed-2 is down-regulated but also ectopically expressed in clear cell renal cell carcinoma. Mol Biol Rep. 41:3651–3657. 2014. View Article : Google Scholar : PubMed/NCBI
27	Xu W, Banerji S, Davie JR, Kassie F, Yee D and Kratzke R: Yin yang gene expression ratio signature for lung cancer prognosis. PLoS One. 8:e687422013. View Article : Google Scholar : PubMed/NCBI
28	Togel L, Nightingale R, Chueh AC, Jayachandran A, Tran H, Phesse T, Wu R, Sieber OM, Arango D, Dhillon AS, et al: Dual targeting of bromodomain and extra-terminal domain proteins, and WNT or MAPK signaling, inhibits c-MYC expression and proliferation of colorectal cancer cells. Mol Cancer Ther. 15:1217–1226. 2016. View Article : Google Scholar : PubMed/NCBI
29	Sempou E, Biasini E, Pinzon-Olejua A, Harris DA and Malaga-Trillo E: Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo. Mol Neurodegener. 11:182016. View Article : Google Scholar : PubMed/NCBI